BlackRock Group’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$33.7M Sell
235,175
-13,329
-5% -$1.91M 0.02% 678
2016
Q3
$29.3M Buy
248,504
+11,789
+5% +$1.39M 0.01% 703
2016
Q2
$25.1M Sell
236,715
-18,256
-7% -$1.93M 0.01% 727
2016
Q1
$28.4M Sell
254,971
-68,653
-21% -$7.65M 0.02% 713
2015
Q4
$50.7M Buy
323,624
+74,087
+30% +$11.6M 0.03% 574
2015
Q3
$32.7M Buy
249,537
+15,686
+7% +$2.06M 0.02% 669
2015
Q2
$40.7M Buy
233,851
+116,221
+99% +$20.2M 0.02% 652
2015
Q1
$20.3M Sell
117,630
-4,900
-4% -$845K 0.01% 805
2014
Q4
$15.9M Sell
122,530
-9,665
-7% -$1.25M 0.01% 850
2014
Q3
$17M Sell
132,195
-15,674
-11% -$2.02M 0.01% 827
2014
Q2
$13.1M Sell
147,869
-34,850
-19% -$3.08M 0.01% 876
2014
Q1
$17.2M Buy
182,719
+9,963
+6% +$937K 0.01% 795
2013
Q4
$19.5M Buy
172,756
+46,137
+36% +$5.22M 0.01% 759
2013
Q3
$9.99M Buy
126,619
+63,678
+101% +$5.02M 0.01% 919
2013
Q2
$4.14M Buy
+62,941
New +$4.14M ﹤0.01% 1024